← Back to Clinical Trials
Recruiting NCT06680934
NCT06680934 CABP2 Patient Registry and Natural History Study
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06680934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Goettingen |
| Condition | CABP2-related Auditory Synaptopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-08-16 |
| Primary Completion | 2049-08-16 |
Trial Parameters
Condition CABP2-related Auditory Synaptopathy
Sponsor University Medical Center Goettingen
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2024-08-16
Completion 2049-08-16
All Conditions
Interventions
Molecular genetic testing and audiometry
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Eligibility Criteria
Inclusion Criteria: * A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry Exclusion Criteria: * Patients with evidence of non-CABP2 molecular genetic diagnoses
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology